RxDoctor Payments Data

Richard Fessler, MD

Neurosurgery · Southfield, MINPI 1801882584

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (54.0%), travel and lodging and education — rather than concentrated in one kind of arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 23.9%. Reporting peaked in 2023 at $3,152 and has fallen 84.6% since, to $486 in 2025.

$7,307in general payments, 2019–2025

Across 90 payments — averaging $81.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$2K
  • Depuy Synthes Products, Inc.$1K
  • Orthofix Medical, Inc.$866
  • Medtronic$734
  • Kuros Biosciences USA, Inc$663
  • Stryker$506
  • plus $2K from 14 others

What the payments were for

  • Travel & lodging$3,34146%
  • Food & beverage$3,94754%
  • Education$200%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few neurosurgery providers in Michiganto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$102,819
Medicare patients
168
Services billed
596

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate26$425
Gabapentin16$157
Naproxen18$81
Mupirocin11$75

Paid to pharmacies, not to this prescriber.

Other neurosurgery in Southfield

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →